NovaMechanics Ltd develops algorithms and solves cheminformatics problems custom made for pharmaceutical companies and institutions and offers administrating and consulting services for patent protection or/and commercialization of scientific results.  

NovaMechanics Ltd is the ideal partner for providing outsourced research to pharma and academic community and thus improving their productivity and efficiency in drug discovery. Our custom made in silico models and simulation tools help to the interpretation of research results and to the design of effective novel patentable compounds.

What We Do

• Computer Assisted Drug Design (CADD)

• Drug Discovery Project Management

• Consulting for REACH

• Contract Resarch Organization (CRO) Management

• Technology Transfer

• Technology Development

• Investor Due Diligence

• ChemInformatics [GR: Χημειοπληροφορική]  

•  Knowledge Management

• Bioinformatics  [GR: Βιοπληροφορική]

• QSAR - QSPR - QSTR

• ADMET

What's New?

May 2009:  NovaMechanics’ published the first LS-SVM & MLR QSAR workflow for predicting the inhibition of CXCR3 in the literature.

March 2009: NovaMechanics’ ligand – based virtual screening optimized procedure highlighted again to the Top25 Hottest Articles (October - December 2008)

January 2009: NovaMecahanics' published a  predicting QSAR workflow for the in silico identification and screening of novel HDAC inhibitors. (more info)

June 2008: NovaMechanics’ published the first QSAR study concerning antagonists of CXCR3 in the literature.

March 2008: NovaMechanics’ ligand – based virtual screening optimized procedure highlighted to the Top25 Hottest Articles (October - December 2007)